Guided Therapeutics (GTHP) Cash & Equivalents (2010 - 2026)
Guided Therapeutics (GTHP) posted Cash & Equivalents of $63000.0 for Q4 2025, down 27.59% sequentially from $87000.0 in Q3 2025, and down 83.76% YoY from $388000.0 in Q4 2024.
Guided Therapeutics (GTHP) Cash & Equivalents (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Cash & Equivalents for 16 years, with the latest figure at $63000.0 in Q4 2025.
- Quarterly Cash & Equivalents fell 83.76% year-over-year to $63000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $63000.0 (down 83.76% YoY) and the FY2025 annual result came in at $63000.0, down 83.76% from the prior year.
- Cash & Equivalents fell to $63000.0 in Q4 2025 per GTHP's latest filing, from $87000.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $2.7 million in Q3 2022 and troughed at $63000.0 in Q4 2025.
- A 5-year average of $790150.0 and a median of $566000.0 in 2021 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2021 and 2025: Cash & Equivalents surged 5838.1% in 2021, then tumbled 83.76% in 2025.
- Over 5 years, Cash & Equivalents stood at $643000.0 in 2021, then jumped by 259.72% to $2.3 million in 2022, then sank by 74.45% to $591000.0 in 2023, then slumped by 34.35% to $388000.0 in 2024, then sank by 83.76% to $63000.0 in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $63000.0, $87000.0, and $185000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 275,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 591,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 725,000.00 |
| Dec 31, 2021 | 643,000.00 |
| Sep 30, 2021 | 541,000.00 |
| Jun 30, 2021 | 922,000.00 |